Astera Labs (ALAB) to Release Earnings on Tuesday

Astera Labs (NASDAQ:ALAB) is projected to issue its Q2 2026 results after the market closes on Tuesday, August 4th. Analysts expect Astera Labs to post earnings of $0.69 per share and revenue of $360.5920 million for the quarter. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. Parties may visit the the company’s upcoming Q2 2026 earning overview page for the latest details on the call scheduled for Tuesday, August 4, 2026 at 4:30 PM ET.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings data on Tuesday, May 5th. The company reported $0.61 earnings per share for the quarter, topping the consensus estimate of $0.54 by $0.07. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The business had revenue of $308.36 million during the quarter, compared to analysts’ expectations of $292.19 million. During the same quarter in the previous year, the company earned $0.33 EPS. The business’s revenue was up 93.5% on a year-over-year basis. On average, analysts expect Astera Labs to post $2 EPS for the current fiscal year and $3 EPS for the next fiscal year.

Astera Labs Price Performance

Shares of NASDAQ ALAB traded down $26.46 during mid-day trading on Tuesday, hitting $256.06. 1,415,743 shares of the stock traded hands, compared to its average volume of 5,514,082. The company has a market cap of $43.89 billion, a PE ratio of 171.71, a price-to-earnings-growth ratio of 3.38 and a beta of 3.66. Astera Labs has a twelve month low of $97.89 and a twelve month high of $499.48. The firm has a 50 day simple moving average of $360.28 and a two-hundred day simple moving average of $226.92.

Insider Activity

In other Astera Labs news, Director Manuel Alba sold 136,974 shares of the business’s stock in a transaction on Wednesday, July 1st. The stock was sold at an average price of $442.01, for a total value of $60,543,877.74. Following the sale, the director directly owned 1,287,524 shares in the company, valued at $569,098,483.24. The trade was a 9.62% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jitendra Mohan sold 139,951 shares of Astera Labs stock in a transaction dated Thursday, May 7th. The stock was sold at an average price of $200.16, for a total transaction of $28,012,592.16. Following the completion of the transaction, the chief executive officer owned 3,929,183 shares of the company’s stock, valued at $786,465,269.28. The trade was a 3.44% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 1,676,845 shares of company stock valued at $444,928,806 over the last three months. Corporate insiders own 10.40% of the company’s stock.

Institutional Trading of Astera Labs

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Smartleaf Asset Management LLC boosted its stake in Astera Labs by 422.2% in the 4th quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock worth $32,000 after purchasing an additional 152 shares during the period. Towarzystwo Funduszy Inwestycyjnych PZU SA purchased a new stake in shares of Astera Labs in the fourth quarter worth about $33,000. Wexford Capital LP purchased a new stake in shares of Astera Labs in the third quarter worth about $39,000. National Bank of Canada FI boosted its position in shares of Astera Labs by 159.0% in the third quarter. National Bank of Canada FI now owns 202 shares of the company’s stock valued at $39,000 after acquiring an additional 124 shares during the period. Finally, Silicon Valley Capital Partners purchased a new position in Astera Labs during the fourth quarter valued at approximately $50,000. 60.47% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

ALAB has been the topic of a number of research reports. Weiss Ratings raised Astera Labs from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, May 21st. Roth Capital restated a “buy” rating and set a $275.00 price target on shares of Astera Labs in a research note on Wednesday, May 6th. Citigroup downgraded shares of Astera Labs from a “buy” rating to a “market perform” rating in a research report on Tuesday, May 26th. UBS Group raised their target price on Astera Labs from $205.00 to $400.00 and gave the company a “neutral” rating in a report on Monday, June 29th. Finally, Rothschild & Co Redburn initiated coverage on Astera Labs in a research report on Friday, May 1st. They issued a “neutral” rating and a $153.00 price target for the company. Twelve investment analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company’s stock. According to data from MarketBeat.com, Astera Labs has a consensus rating of “Moderate Buy” and an average target price of $282.00.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.